Greg F. Walker
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 18
- Advanced biosensing and bioanalysis techniques 10
-
- Advanced Drug Delivery Systems 6
- Drug Solubulity and Delivery Systems 4
- Co-authors
- Andreas Bernkop‐Schnürch (6 shared papers)Ernst Wagner (9 shared papers)Verena M. Leitner (1 shared paper)Manfred Ogris (4 shared papers)Ralf Kircheis (2 shared papers)Jaroslav Pelisek (3 shared papers)Sarah L. Young (10 shared papers)Sabine Boeckle (1 shared paper)
- Journals
- International Journal of Pharmaceutics (4 papers)Journal of Pharmaceutical Sciences (2 papers)Bioconjugate Chemistry (2 papers)European Journal of Pharmaceutical Sciences (2 papers)Molecular Therapy (2 papers)
- Partner nations
- New ZealandGermanyAustria
In The Last Decade
Greg F. Walker
46 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 125
- Pharmaceutical Science 521
- Biomaterials 370
- Molecular Medicine 89
- Molecular Biology 1.2k
- Genetics 378
Countries citing papers authored by Greg F. Walker
This map shows the geographic impact of Greg F. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg F. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg F. Walker more than expected).
Fields of papers citing papers by Greg F. Walker
This network shows the impact of papers produced by Greg F. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg F. Walker. The network helps show where Greg F. Walker may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg F. Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 316 | |
| 2 | 2004 | 271 | |
| 3 | 2002 | 238 | |
| 4 | 2018 | 119 | |
| 5 | 2007 | 111 | |
| 6 | 2004 | 85 | |
| 7 | 2008 | 73 | |
| 8 | 2001 | 66 | |
| 9 | 2001 | 65 | |
| 10 | 2008 | 61 | |
| 11 | 1967 | 50 | |
| 12 | 2005 | 49 | |
| 13 | 2004 | 47 | |
| 14 | 2017 | 43 | |
| 15 | 2017 | 38 | |
| 16 | 2006 | 38 | |
| 17 | 2009 | 35 | |
| 18 | 2017 | 34 | |
| 19 | 1993 | 32 | |
| 20 | 2002 | 32 |
About Greg F. Walker
Greg F. Walker is a scholar working on Molecular Biology, Pharmaceutical Science, Immunology, Biomaterials and Biomedical Engineering, having authored 47 papers that have together received 2.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (18 papers), Advanced biosensing and bioanalysis techniques (10 papers), Immunotherapy and Immune Responses (8 papers), Advanced Drug Delivery Systems (6 papers), Electrospun Nanofibers in Biomedical Applications (5 papers), Peptidase Inhibition and Analysis (4 papers), Drug Solubulity and Delivery Systems (4 papers) and Neuropeptides and Animal Physiology (4 papers). The work is most often cited by research in Pharmaceutical Science (521 citations), Biomaterials (370 citations), Molecular Medicine (89 citations), Molecular Biology (1.2k citations) and Genetics (378 citations). Greg F. Walker has collaborated with scholars based in New Zealand, Germany and Austria. Frequent co-authors include Andreas Bernkop‐Schnürch, Ernst Wagner, Verena M. Leitner, Manfred Ogris, Ralf Kircheis, Jaroslav Pelisek, Sarah L. Young, Sabine Boeckle, Malgorzata Kursa and Wolfgang Röedl. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences, Bioconjugate Chemistry, European Journal of Pharmaceutical Sciences and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.